We previously reported that tumor-specific Caveolin-1 (CAV1) was prognostic for both contralateral breast cancer (CAV1 in malignant cells) and locoregional recurrence (CAV1 in stromal cells) [13]. This evidence concerns the gene CAV1 and breast cancer.